New discovery in Alzheimer's protein puzzle

May 14, 2012 By Raquel Maurier in Alzheimer's disease & dementia

(Medical Xpress) -- A medical research team at the University of Alberta has made two related discoveries that could shed more light on Alzheimer’s disease.

Faculty of Medicine & Dentistry researcher Elena Posse de Chaves and her team recently published their findings in The Journal of Neuroscience.

It has been known for decades that plays an important role in Alzheimer’s . Posse de Chaves’ team discovered that, in brain cells that accumulate toxic levels of the normally occurring beta amyloid , “there is a significant inhibition” in the process that creates brain cholesterol.

Brain cholesterol is vital for normal brain function because it helps protect neurons and helps brain cells fire properly.

What the discovery means is that the relationship between this naturally occurring protein and cholesterol is not just one-way. These findings have been suggested by other research teams as well.

“Our work supports the idea that there is a two-way relationship,” said Posse de Chaves, a researcher in the Department of Pharmacology.

Her team’s work is also important in another area. Those who have Alzheimer’s disease have low levels of a protein known as seladin-1. Some researchers believe this could be an indicator for the disease. This protein is part of the process that leads to the creation of cholesterol. So if cholesterol production is inhibited in Alzheimer’s disease, as demonstrated by the U of A findings, this could explain why levels of the seladin-1 protein are so low.  

“Our findings could explain why that one protein is decreased in the brains of patients with Alzheimer’s disease,” said Posse de Chaves. “This is one piece of the puzzle and every discovery helps.”

According to the Alzheimer Society of Canada, more than 500,000 people in Canada and more than 35 million worldwide have dementia, a group of disorders that includes Alzheimer’s disease.  

The Canadian Institutes of Health Research and the Alzheimer Society of Canada funded the research.

Provided by University of Alberta search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts
  • Magnetic field and repulsion bewteen wires
    created3 hours ago
  • Enthalpy of reaction
    created9 hours ago
  • Harmonic oscillation problem -Dancing pot
    created10 hours ago
  • Ultracapacitor to power electromagnet?
    created10 hours ago
  • Confusion in Electro Statics
    created11 hours ago
  • simple gravity question
    created12 hours ago
  • More from Physics Forums - Classical Physics

More news stories

Scientists identify molecular trigger for Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...

Alzheimer's disease & dementia created 3 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Alzheimer's disease & dementia created May 19, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.

Alzheimer's disease & dementia created May 19, 2013 | popularity not rated yet | comments 0

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...

Alzheimer's disease & dementia created May 17, 2013 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Nonmelanoma skin cancer tied to lower Alzheimer's risk

(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.

Alzheimer's disease & dementia created May 16, 2013 | popularity 5 / 5 (1) | comments 0


Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...

Practice makes perfect? Not so much

Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...

Older prostate cancer patients should think twice before undergoing treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...

New test better detects elephantiasis worm infection

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...

Study shows that women who smoke during pregnancy increase the risk of both obesity and gestational diabetes in their da

Women who smoke during pregnancy increase the risk of both obesity and gestational diabetes, in their daughters, concludes research published in Diabetologia, the journal of the European Association for the Study of Diabet ...

Leading researchers report on the elusive search for biomarkers in Huntington's disease

While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends ...